West Roxbury, MA, United States of America

Thomas E Van Dyke

This inventor holds 10 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Boston University, Forsyth Dental Infirmary for Children, The Brigham and Women's Hospital, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas E Van Dyke. Retrieved from https://idiyas.com/inventor/thomas-e-van-dyke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 9)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 16(Granted Patents)

Company Filing History:

Forsyth Dental Infirmary for Children

patents

4 out of 1,429

The Brigham and Women's Hospital, Inc.

patents

4. 4 out of 1,695

University of Southern California

The Forsyth Institute

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527760 - Synthesis of pro-resolving analogs and compositions therefor (2026-01-20),

2. 11903998 - Compositions and methods of treating cancer using lipid agonists and receptors thereof (2024-02-20),

3. 11896571 - Methods for increasing oral osteogenesis using lipoxin A(LXA) and its analogs (2024-02-13),

4. 10434080 - Methods for increasing oral osteogenesis using lipoxin A4 (LXA4) and its analogs (2019-10-08),

5. 9968577 - Treatment and prevention of bone loss using resolvins (2018-05-15),

6. 8636986 - Treatment and prevention of bone loss using resolvins (2014-01-28),

7. 8604229 - Lipoxin analogs and methods for the treatment of periodontal disease (2013-12-10),

8. 8093417 - Lipoxin analogs and methods for the treatment of periodontal disease (2012-01-10),

9. 7812054 - Lipoxin analogs and methods for the treatment of periodontal disease (2010-10-12),

10. 7700650 - Lipoxin analogs and method for the treatment of periodontal disease (2010-04-20),

Title: Innovations and Contributions of Thomas E Van Dyke

Introduction

Thomas E Van Dyke is a prominent inventor based in West Roxbury, MA (US). He has made significant contributions to the field of medical science, particularly in cancer treatment and oral health. With a total of nine patents to his name, Van Dyke's work has had a profound impact on therapeutic methods.

Latest Patents

Among his latest patents, one notable invention is focused on compositions and methods of treating cancer using lipid agonists and their receptors. This patent outlines methods for preventing or treating cancer by overexpressing specific receptors for lipid agonists, such as G-protein receptors for Resolvin. The methods may be combined with the administration of Resolvins or lipoxins and their analogs to enhance pro-resolution effects in the inflammatory environment where cancer cells are present. Another significant patent involves methods for increasing oral osteogenesis using lipoxin A (LXA) and its analogs. This invention provides methods for treating or preventing oral disorders that would benefit from increased oral osteogenesis.

Career Highlights

Throughout his career, Thomas E Van Dyke has worked with esteemed institutions such as Boston University and The Brigham and Women's Hospital, Inc. His research and innovations have contributed to advancements in medical treatments and therapies.

Collaborations

Van Dyke has collaborated with notable individuals in his field, including Nicos A Petasis and Charles Nicholas Serhan. These collaborations have further enriched his research and development efforts.

Conclusion

Thomas E Van Dyke's innovative work and numerous patents reflect his dedication to improving health outcomes through scientific research. His contributions continue to influence the fields of cancer treatment and oral health.

Profile summary based on public USPTO records.